Microarrays and breast cancer clinical studies: Forgetting what we have not yet learnt

Breast Cancer Research

Volumn 7, Issue 3, 2005, Pages 96-99

  Ashour Ahmed, Ahmed ^a   Brenton, James D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RESEARCH; COHORT ANALYSIS; DIAGNOSTIC VALUE; DNA MICROARRAY; EXPERIMENTAL DESIGN; HUMAN; INFORMATION PROCESSING; METHODOLOGY; OUTCOMES RESEARCH; PATIENT SELECTION; PREDICTION; PROCESS OPTIMIZATION; PROGNOSIS; REPRODUCIBILITY; REVIEW; STANDARDIZATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VALIDATION PROCESS;

BREAST NEOPLASMS; CLINICAL TRIALS; ENDPOINT DETERMINATION; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 18944391930     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr1017     Document Type: Review

References (31)

1. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al.: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874.
2. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al.: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
3. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, et al.: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002, 347:1999-2009.
4. Ahr A, Karn T, Solbach C, Seiter T, Strebhardt K, Holtrich U, Kaufmann M: Identification of high risk breast-cancer patients by gene expression profiling. Lancet 2002, 359:131-132.
5. Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, et al.: Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 2003, 362:362-369.
6. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL, Liu ET: Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003, 100: 10393-10398.
7. Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, Horng CF, Bild A, Iversen ES, Liao M, Chen CM, et al.: Gene expression predictors of breast cancer outcomes. Lancet 2003, 361:1590-1596.
8. Liu ET, Karuturi KR: Microarrays and clinical investigations. N Engl J Med 2004, 350:1595-1597.
9. Wang E, Miller LD, Ohnmacht GA, Liu ET, Marincola FM: High-fidelity mRNA amplification for gene profiling. Nat Biotechnol 2000, 18:457-459.
10. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, et al.: Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 1999, 96: 9212-9217.
11. Hu L, Wang J, Baggerly K, Wang H, Fuller GN, Hamilton SR, Coombes KR, Zhang W: Obtaining reliable information from minute amounts of RNA using cDNA microarrays. BMC Genomics 2002, 3:16.
12. 't Hoen PA, de Kort F, van Ommen GJ, den Dunnen JT: Fluorescent labelling of cRNA for microarray applications. Nucleic Acids Res 2003, 31:e20.
13. Naderi A, Ahmed AA, Barbosa-Morais NL, Aparicio S, Brenton JD, Caldas C: Expression microarray reproducibility is improved by optimising purification steps in RNA amplification and labelling. BMC Genomics 2004, 5:9.
14. Hughes TR, Mao M, Jones AR, Burchard J, Marton MJ, Shannon KW, Lefkowitz SM, Ziman M, Schelter JM, Meyer MR, et al.: Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol 2001, 19:342-347.
15. Taylor S, Smith S, Windle B, Guiseppi-Elie A: Impact of surface chemistry and blocking strategies on DNA microarrays. Nucleic Acids Res 2003, 31:e87.
16. Lee JK, Bussey KJ, Gwadry FG, Reinhold W, Riddick G, Pelletier SL, Nishizuka S, Szakacs G, Annereau JP, Shankavaram U, et al.: Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells. Genome Biol 2003, 4:R82.
17. Zorn KK, Jazaeri AA, Awtrey CS, Gardner GJ, Mok SC, Boyd J, Birrer MJ: Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies. Clin Cancer Res 2003, 9:4811-4818.
18. Ahmed AA, Vias M, Iyer NG, Caldas C, Brenton JD: Microarray segmentation methods significantly influence data precision. Nucleic Acids Res 2004, 32:e50.
19. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, et al.: Minimum information about a microarray experiment (MIAME) - toward standards for microarray data. Nat Genet 2001, 29: 365-371.
20. Park PJ, Cao YA, Lee SY, Kim JW, Chang MS, Hart R, Choi S: Current issues for DNA microarrays: platform comparison, double linear amplification, and universal RNA reference. J Biotechnol 2004, 112:225-245.
21. Tan PK, Downey TJ, Spitznagel EL Jr, Xu P, Fu D, Dimitrov DS, Lempicki RA, Raaka BM, Cam MC: Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res 2003, 31:5676-5684.
22. Tumor Analysis Best Practices Working Group: Expression profiling - best practices for data generation and interpretation in clinical trials. Nat Rev Genet 2004, 5:229-237.
23. Altman DG: Systematic reviews of evaluations of prognostic variables. BMJ 2001, 323:224-228.
24. Riley RD, Abrams KR, Sutton AJ, Lambert PC, Jones DR, Heney D, Burchill SA: Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. Br J Cancer 2003, 88:1191-1198.
25. Chollet P, Amat S, Cure H, de Latour M, Le Bouedec G, Mouret-Reynier MA, Ferriere JP, Achard JL, Dauplat J, Penault-Llorca F: Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. Br J Cancer 2002, 86:1041-1046.
26. Simon R: Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data. Br J Cancer 2003, 89:1599-1604.
27. Simon R: When is a genomic classifier ready for prime time? Nat Clin Pract Oncol 2004, 1:4-5.
28. Tibshirani RJ, Effron B: Pre-validation and inference in microarrays. Statist Applic Genet Mol Biol 2002, 1 (1):article 1.
29. Ihaka R, Gentleman R: R: a language for data analysis and graphics. J Comput Graph Stat 1996, 5:299-314.
30. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al.: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80.
31. Ruschhaupt M, Huber W, Poustka A, Mansmann U: A compendium to ensure computational reproducibility in high-dimensional classification tasks. Statist Applic Genet Mol Biol 2004, 3:article 37.